Innovative Platform Nuritas utilizes a proprietary AI-powered platform to discover and develop unique bioactive peptides, providing opportunities to collaborate on personalized health ingredients and functional products tailored for health-conscious brands seeking scientifically backed solutions.

Growing Investment With over $98 million in funding and recent high-profile investments from M&G Plc and other investors, Nuritas is expanding its R&D capabilities and commercial reach, opening avenues to sell advanced ingredients and licensing partnerships across global markets.

Product Launches Recent introductions of innovative peptides like PeptiSleep, PeptiYouth, and PeptiStrong demonstrate a focus on functional, health-oriented products—potential opportunities to supply ingredients or partner with supplement and skincare brands aiming to incorporate science-driven ingredients.

Market Expansion Nuritas has expanded into the U.S. market with a North American headquarters, which enhances its regional presence—this provides a strategic entry point for sales teams seeking to position innovative biotech solutions to North American health, nutrition, and beauty companies.

Industry Recognition Participation in leading industry events like Natural Products Expo West and ongoing funding rounds indicate strong visibility and credibility in the biotech and wellness sectors, facilitating introductions to innovative brands and manufacturers interested in science-based development partnerships.